Performance analysis of Rigel Pharmaceuticals (RIGL)
Annual Return
Over the past 3 years, RIGL has had an average annual return of +45.24%, outperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, RIGL has had an average annual return of -1.03%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, RIGL has had an average annual return of +5.80%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Nov 29, 2000, RIGL has had an average annual return of -10.27%, underperforming the benchmark SPY, which returned +8.85% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.32% | +154.37% | +15.86% | -2.99% | -43.48% | -24.31% | +63.77% | -6.96% | -40.76% | +62.90% | -21.52% | +33.52% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -20.22% | -56.20% | -17.60% | +4.76% | -20.79% | +18.88% | -68.50% | +113.91% | +42.04% | -65.78% | +27.20% | +93.92% |
| 2002 | 2001 | 2000 | |||||||||
| -76.35% | -53.50% | +40.65% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.54% | -0.37% | -22.10% | +6.86% | +5.31% | +28.36% | +1.47% | -7.32% | |||||
| 2025 | +28.52% | +6.51% | -21.94% | +8.90% | -1.96% | -2.33% | +12.29% | +84.50% | -27.02% | +11.51% | +59.72% | -15.21% | +154.37% |
| 2024 | -19.38% | +30.05% | -2.94% | -29.00% | -6.71% | -16.34% | +28.91% | +27.27% | +20.48% | -15.81% | +102.35% | -38.98% | +15.86% |
| 2023 | +9.40% | -7.81% | -12.71% | -14.08% | +23.73% | -7.76% | +6.93% | -17.59% | -5.06% | -25.44% | +41.27% | +27.53% | -2.99% |
| 2022 | -3.38% | -2.00% | +19.13% | -20.99% | -23.31% | -37.46% | +5.08% | +19.35% | -17.12% | -38.04% | -7.89% | +122.86% | -43.48% |
| 2021 | +4.02% | +14.06% | -17.72% | +8.80% | +0% | +16.70% | -7.82% | -4.96% | -4.55% | -7.41% | -20.57% | -0.72% | -24.31% |
| 2020 | +5.69% | -6.23% | -26.28% | +14.75% | +9.29% | -6.54% | +25.52% | +8.36% | -3.60% | +3.47% | +22.16% | +15.40% | +63.77% |
| 2019 | -5.85% | +1.18% | +17.54% | -13.43% | -4.31% | +22.52% | -12.75% | -25.84% | +10.61% | +9.59% | +9.37% | -4.57% | -6.96% |
| 2018 | +3.14% | -5.92% | -5.95% | +1.99% | -9.93% | -12.99% | -0.23% | +20.86% | -5.82% | -10.56% | -1.56% | -18.78% | -40.76% |
| 2017 | -12.63% | +17.85% | +34.99% | -9.67% | -23.34% | +19.27% | -13.35% | +7.57% | -0.25% | +47.61% | +10.92% | -6.77% | +62.90% |
Drawdown analysis of Rigel Pharmaceuticals (RIGL)
The maximum drawdown for the RIGL was -99.37%, occurring on Jun 10, 2022. This drawdown has not yet recovered.
The current RIGL drawdown is -96.29%.
Since Nov 29, 2000 RIGL has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.37% | Jan 3, 2001 | 5393 | Jun 10, 2022 | Ongoing | Ongoing | Ongoing |
| -20.55% | Dec 12, 2000 | 6 | Dec 20, 2000 | 4 | Dec 27, 2000 | 10 |
| -5.33% | Dec 5, 2000 | 2 | Dec 7, 2000 | 2 | Dec 11, 2000 | 4 |
| -0.70% | Nov 29, 2000 | 1 | Nov 30, 2000 | 1 | Dec 1, 2000 | 2 |